NRSN NeuroSense Therapeutics Ltd. - Ordinary Shares
$0.43
Price · Aug 18, 2026
52W Range
$0–$2
2% of range
Analyst Rating
BUY
9 analysts
Price Target
$6
+1412% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—
NRSN Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$0.43
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$0 – $2
NRSN Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
NRSN
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
NRSN
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
NRSN
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
NRSN
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
NRSN
Peer Median
NRSN Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
9 analysts
- Strong Buy 2 22.2%
- Buy 6 66.7%
- Hold 1 11.1%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
3 analysts · 2026-08-16
Median
$7.50
Mean
$6.50
← Below all targets
$0.43
Low
$3.00
High
$9.00
Median target
$7.50
+1644.2%
Mean target
$6.50
+1411.6%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
0.03%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| June 30, 2025 | $-0.19 | $-0.20 | 0.01% |
| Dec. 31, 2024 | $-0.06 | $-0.12 | 0.06% |
| Sept. 30, 2024 | $-0.11 | $-0.16 | 0.05% |
| June 30, 2024 | $-0.02 | $-0.20 | 0.18% |
| March 31, 2024 | $-0.35 | $-0.21 | -0.14% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| NRSN | — | — | — | — | — | — |
| ENLV | — | — | — | — | — | — |
| PLRZ | — | — | — | — | — | — |
| PLUR | $39M | -1.4 | 309.8% | -1690.3% | 669.5% | 48.9% |
| CMMB | — | — | — | — | — | — |
| QNRX | $757M | — | — | — | -201.7% | — |
| EVGN | — | — | — | — | — | — |
| CLGN | — | — | — | — | — | — |
| URGN | $1.13B | — | 21.4% | -139.8% | 154.4% | 88.7% |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 12 filers · $270K total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 2 (-1 vs prior Q) | 3 (+1 vs prior Q) | 2 (+2 vs prior Q) | 2 (-2 vs prior Q) | +42K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Independent Advisor Alliance | $72,000 | 100,000 | 26.70% | Shares |
| UBS Group AG | $69,120 | 96,000 | 25.63% | Shares |
| Yorkville Advisors Global, LP | $56,160 | 78,000 | 20.83% | Shares |
| COMMONWEALTH EQUITY SERVICES, LLC | $16,400 | 22,775 | 6.08% | Shares |
| PNC Financial Services Group, Inc. | $15,228 | 21,150 | 5.65% | Shares |
| Pathstone Holdings, LLC | $11,900 | 16,528 | 4.41% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $11,426 | 15,870 | 4.24% | Shares |
| XTX Topco Ltd | $8,261 | 11,473 | 3.06% | Shares |
| Creative Planning | $8,215 | 11,410 | 3.05% | Shares |
| JONES FINANCIAL COMPANIES LLLP | $757 | 1,000 | 0.28% | Shares |
| SBI Securities Co., Ltd. | $184 | 255 | 0.07% | Shares |
| HRT FINANCIAL LP | $7 | 10,515 | 0.00% | Shares |
Company insiders 3 insiders · 3 officers · 0 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Or Eisenberg | Chief Financial Officer | March 26, 2026 A | 1,254,050 | 0 | 0 | $0 |
| Niva Russek-Blum | Chief Technology Officer | March 26, 2026 A | 467,953 | 0 | 0 | $0 |
| Hagit Binder | General Manager | March 26, 2026 A | 521,806 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only